Home  >  Products  >  KCTD1 (potassium channel tetramerisation domain containing 1 ) Blocking Peptide (the C terminal of KCTD1)(100ug)
KCTD1 (potassium channel tetramerisation domain containing 1 ) Blocking Peptide (the C terminal of KCTD1)(100ug)

KCTD1 (potassium channel tetramerisation domain containing 1 ) Blocking Peptide (the C terminal of KCTD1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KCTD1 Antibody (ARP67597_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67597
Size: 100ug
Weight: 95kDa
Gene: 284252
Format: Lyophilized powder
Target: KCTD1 may repress the transcriptional activity of AP-2 family members, including TFAP2A, TFAP2B and TFAP2C to various extent.
Alternative names: C18orf5
See Full Product Listings >